NMR characterization of interleukin‐2 in complexes with the IL‐2Rα receptor component, and with low molecular weight compounds that inhibit the IL‐2/IL‐Rα interaction

Nuclear magnetic resonance (NMR) methods were employed to study the interaction of the cytokine Interleukin‐2 (IL‐2) with the α‐subunit of its receptor (IL‐2Rα), and to help understand the behavior of small molecule inhibitors of this interaction. Heteronuclear 1H‐15N HSQC experiments were used to i...

Full description

Saved in:
Bibliographic Details
Published inProtein science Vol. 12; no. 4; pp. 811 - 822
Main Authors Emerson, S. Donald, Palermo, Robert, Liu, Chao‐Min, Tilley, Jefferson W., Chen, Li, Danho, Waleed, Madison, Vincent S., Greeley, David N., Ju, Grace, Fry, David C.
Format Journal Article
LanguageEnglish
Published Bristol Cold Spring Harbor Laboratory Press 01.04.2003
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Nuclear magnetic resonance (NMR) methods were employed to study the interaction of the cytokine Interleukin‐2 (IL‐2) with the α‐subunit of its receptor (IL‐2Rα), and to help understand the behavior of small molecule inhibitors of this interaction. Heteronuclear 1H‐15N HSQC experiments were used to identify the interaction surface of 15N‐enriched Interleukin‐2 (15N‐IL‐2) in complex with human IL‐2Rα. In these experiments, chemical shift and line width changes in the heteronuclear single‐quantum coherence (HSQC) spectra upon binding of 15N‐IL‐2 enabled classification of NH atoms as either near to, or far from, the IL‐2Rα interaction surface. These data were complemented by hydrogen/deuterium (H/D) exchange measurements, which illustrated enhanced protection of slowly‐exchanging IL‐2 NH protons near the site of interaction with IL‐2Rα. The interaction surface defined by NMR compared well with the IL‐2Rα binding site identified previously using mutagenesis of human and murine IL‐2. Two low molecular weight inhibitors of the IL‐2/IL‐2Rα interaction were studied: one (a cyclic peptide derivative) was found to mimic a part of the cytokine and bind to IL‐2Rα; the other (an acylphenylalanine derivative) was found to bind to IL‐2. For the interaction between IL‐2 and the acylphenylalanine, chemical shift perturbations of 15N and 15NH backbone resonances were tracked as a function of ligand concentration. The perturbation pattern observed for this complex revealed that the acylphenylalanine is a competitive inhibitor—it binds to the same site on IL‐2 that interacts with IL‐2Rα.
Bibliography:Reprint requests to: David C. Fry, Hoffmann-La Roche Inc., Bldg. 123, Room 3115, 340 Kingsland Street, Nutley, NJ 07110-1199, USA; e-mail: david.fry@roche.com; fax: (973) 235-6084.
Article and publication are at http://www.proteinscience.org/cgi/doi/10.1110/ps.0232803.
Present address: Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 07033, USA.
Present address: Pfizer Inc., 2800 Plymouth Road, Ann Arbor, MI 48105, USA.
ISSN:0961-8368
1469-896X
DOI:10.1110/ps.0232803